drugset / Press release
CSF1R inhibition with emactuzumab in locally advanced diff use-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study
2015-07-13 · SynOx Therapeutics Limited · original synoxtherapeutics.com ↗
Click the button below to download the press release or publication. Download
The release as fetched from its publisher. synoxtherapeutics.com ↗